发明名称 SULFONAMIDE FOR TREATING ENDOTHELIN-MEDIATED DISORDER
摘要 PROBLEM TO BE SOLVED: To provide a compound for regulating the activity of an endothelin (ET) peptide, and to provide a formulation for administering the compound to mammals referring to the fact that a vascular endothelium releases various vasoactive materials such as endothelin (ET), etc., which is a vasoconstrictive peptide originating from endothelium. SOLUTION: Thienyl-, furyl- and pyrrolyl-sulfonamides; pharmaceutically permissible salts of sulfonamides; formulations of the salts and the sulfonamides; and methods for modulating or altering the activity of the peptides of the family of endothelin using the formulations and sulfonamides are provided. In particular, formulations of sodium salts of N-(isooxazolyl)thienylsulfonamides, N-(isooxazolyl)furylsulfonamides and N-(isooxazolyl)pyrrolylsulfonamides are provided. A method for preparing an alkali metal salt of hydrophobic sulfonamides is provided. The method includes a step of dissolving a free sulfonamide in an organic solvent in the presence of a saturated alkali metal salt solution and a step of recovering the formed sulfonamide salt from the organic solvent. COPYRIGHT: (C)2008,JPO&INPIT
申请公布号 JP2008208143(A) 申请公布日期 2008.09.11
申请号 JP20080127052 申请日期 2008.05.14
申请人 ENCYSIVE PHARMACEUTICALS INC 发明人 WU CHENGDE;BLOK NATALIE;KOGAN TIMOTHY;KELLER KARIN;WOODARD PATRICIA
分类号 C07D413/12;A61K9/19;A61K9/20;A61K9/48;A61K31/422;A61K47/26;A61P1/00;A61P9/00;A61P9/12;A61P11/00;A61P11/06;A61P13/12;A61P15/00;A61P15/02;A61P17/02;A61P27/02;A61P29/00;C07D261/16;C07D409/12;C07D413/14;C07D417/14 主分类号 C07D413/12
代理机构 代理人
主权项
地址